Norges Bank’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Norges Bank’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-99,664	Closed	-$2.75M	–	2377
2021 Q2	$2.75M	Sell	99,664 -35,103	-26%	-$690K	﹤0.01%	1974
2021 Q1	$2.22M	Sell	134,767 -150,213	-53%	-$3.42M	﹤0.01%	1988
2020 Q4	$5.25M	Sell	284,980 -451,600	-61%	-$8.08M	﹤0.01%	1866
2020 Q3	$10M	Buy	736,580 +102,917	+16%	+$1.59M	﹤0.01%	1708
2020 Q2	$11.4M	Buy	633,663 +492,863	+350%	+$7.43M	﹤0.01%	1687
2020 Q1	$1.4M	Hold	140,800	–	–	﹤0.01%	1956
2019 Q4	$1.15M	Hold	140,800	–	–	﹤0.01%	2016
2019 Q3	$1.4M	Buy	140,800 +105,800	+302%	+$999K	﹤0.01%	2017
2019 Q2	$442K	Hold	35,000	–	–	﹤0.01%	2063
2019 Q1	$357K	Hold	35,000	–	–	﹤0.01%	2088
2018 Q4	$263K	Hold	35,000	–	–	﹤0.01%	2093
2018 Q3	$350K	Hold	35,000	–	–	﹤0.01%	2109
2018 Q2	$443K	Buy	+35,000	New	+$423K	﹤0.01%	2093

Norges Bank's TBIO Position: Q3 2021 in Review

Norges Bank sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 99,664 shares — an estimated $2.75M sold.

Norges Bank first reported a position in TBIO in Q2 2018 and held it in 13 quarters. The position peaked at $11.4M in Q2 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Norges Bank reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Norges Bank sold 99,664 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $2.75M.
Norges Bank first reported a position in Translate Bio, Inc. Common Stock in Q2 2018 and held it in 13 quarters.
Norges Bank's Translate Bio, Inc. Common Stock position peaked at $11.4M in Q2 2020.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Norges Bank's 13F filing for Q3 2021, filed 5 Nov 2021.